Newsroom

Stay up to date with the latest news from EY — and see how we’re building a better working world.

Media inquiries

Contact the Japan PR team


Featured press releases

Survey on the Challenges Faced by Healthcare Professionals in Rare Diseases

EY Strategy and Consulting Co., Ltd. (Chiyoda-ku, Tokyo; President and CEO, Akira Kondo; EYSC) supported the planning and operation of a "Survey on the Challenges Faced by Healthcare Professionals in Rare Diseases," in collaboration with Initiative on Rare and Undiagnosed Diseases (IRUD), Rare Disease Consortium Japan (RDCJ), and Japan Pharmaceutical Manufacturers Association (JPMA). EY is pleased to announce that a report of the survey results is now available.

07 Feb 2025 | EY Japan

Smaller, smarter deals: Dealmaking volume stable but value is down as life sciences companies turn to innovative early-stage assets with China and AI becoming major sources of innovation

LONDON, 13 JANUARY 2025. The global life sciences industry has pivoted from major dealmaking to smaller, smarter and more agile deals with mergers and acquisitions (M&A) investment totaling US$130b in 2024, a 41% decrease compared with US$222b in 2023, as the industry turned away from the big deals for de-risked assets that characterized 2023.

13 Jan 2025 | London, GBR | EY Global